BlockBeats News, November 21st, informed sources revealed that the prediction market platform Kalshi has raised $1 billion in its latest funding round, valuing the company at $11 billion. This is less than two months after the seven-year-old startup announced a $300 million funding round and a $5 billion valuation.
Insiders indicated that this round of funding was led by Kalshi's existing shareholders Sequoia Capital and CapitalG. Other investors also include a16z, Paradigm, Anthos Capital, and Neo.
According to Bloomberg, Kalshi's main competitor Polymarket was also in talks for a new funding round last month, with a valuation range of $12 billion to $15 billion. Just a few weeks ago, Polymarket completed a $1 billion funding round at an $8 billion pre-money valuation.
Since last year, both Kalshi and Polymarket have seen a significant increase in popularity as they both allow users to bet on the outcome of presidential elections. Earlier this month, both platforms accurately predicted the results of the New York City mayoral election, further boosting the visibility of these prediction betting websites.
Kalshi allows users from over 140 countries to bet on various future events, ranging from Time magazine's 2025 Person of the Year, the Rotten Tomatoes rating of the movie "Wicked," to longer-term events such as the ultimate winner of the next U.S. presidential election.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.






Key Takeaways Bybit plans to introduce “MyBank” dollar accounts in partnership with licensed financial institutions, enhancing seamless conversion…









Latest Crypto Market Snapshot as of August 22, 2025 BTC Soars to $115,250.00 ETH Hits $4,450.75 XRP Climbs…

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.














Key Takeaways Bybit plans to introduce “MyBank” dollar accounts in partnership with licensed financial institutions, enhancing seamless conversion…